Search

Your search keyword '"Parry-Jones, Nilima"' showing total 8 results
Start Over Author "Parry-Jones, Nilima" Search Limiters Full Text
8 results on '"Parry-Jones, Nilima"'

3. Ethnic Disparities in Waldenström's Macroglobulinaemia in the United Kingdom - Analysis from the Wmuk Rory Morrison Registry

Author

Patel, Aisha S, primary, Khwaja, Jahanzaib, additional, McCarthy, Helen, additional, Pratt, Guy, additional, Kothari, Jaimal, additional, Lindsay, Jindriska, additional, Owen, Roger G, additional, Crowe, Josephine, additional, El-Sharkawi, Dima, additional, Parry-Jones, Nilima, additional, Cuthill, Kirsty, additional, Atta, Maria, additional, Linton, Kim, additional, Parcharidou, Agapi, additional, Kyriakou, Charalampia, additional, Turner, Deborah, additional, Smith, Jeffery, additional, Gatto, Simona, additional, Crosbie, Nicola, additional, Arulogun, Suzanne O, additional, and D'Sa, Shirley, additional

Published
2021
Full Text
View/download PDF

5. The Impact of Pausing Bruton Tyrosine Kinase Inhibitor Therapy and Responsiveness of Vaccination in Blood Cancer Patients: Primary Outcome Result for the Randomised Improve Trial

Author

Patten, Piers, Cook, Jonathan, Peckham, Nicholas, Moss, Paul, Phillips, Neil, Abhishek, Abhishek, Roberts, Thomas, Talbot, Georgina, Barber, Vicki, Francis, Anne, Ashford, Fiona, Duley, Lelia, Hoogeboom, Robbert, Willett, Brian, Parry-Jones, Nilima, Eyre, Toby A., Wandroo, Farooq Ahmad, Hutchinson, Claire, Murray, Duncan James, Vandici, Gratian, Martinez-Calle, Nicolas, Jenkins, Stephen, and Parry, Helen M

Abstract

Background:

Published
2023
Full Text
View/download PDF

8. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.

Author

Del Giudice I, Matutes E, Osuji N, Parry-Jones N, Swansbury J, and Catovsky D

Subjects
Adult, Aged, Cyclophosphamide pharmacology, Female, Humans, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Vidarabine pharmacology, Antineoplastic Agents pharmacology, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy, Vidarabine analogs & derivatives, Waldenstrom Macroglobulinemia drug therapy
Abstract

We retrospectively reviewed time to response and incidence of delayed responses in 13 patients with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia (LPL/WM) treated with fludarabine with or without cyclophosphamide. During follow-up post-treatment, seven delayed responses (54%) were observed, improving the initial overall response rate of 61% to a final response rate of 77%.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results